On Monday, the Senate Health Regulation Committee rejected an attempt by Chairman Rene Garcia to amend a repeal of the drug database onto S.B. 818 by Sen. Fasano. S.B. 818 strengthens a number of provisions related to controlled substances, but does not repeal the drug database. Supporters of the database rejected privacy concerns and pointed to the more than 30 states that operate similar systems. Meanwhile, on the same day, Gov. Scott launched a strike force to combat the state's pill mill epidemic, made up of squads in each of Florida Department of Law Enforcement's seven regions throughout the state. Gov. Scott also appeared to endorse the dispensing ban favored by the House, albeit with certain exceptions. In the House on Wednesday, the Judiciary Committee voted out an amended H.B. 7095, which substantially revises the regulation of controlled substances. The original bill, among other provisions, repealed pain clinic regulations, prohibited physicians from dispensing controlled substances in their offices, and banned wholesale drug distributors from distributing such drugs to physicians and dentists. The bill also required wholesale distributors to buy back undispensed drugs held by physicians and dentists. A strike all amendment offered by Rep. Charles McBurney and adopted by the committee deleted the restrictions on wholesale distributors and narrowed the dispensing ban to Schedule II and III drugs, the controlled substances that are most susceptible to abuse. The amendment also bans community pharmacies from dispensing these drugs unless the pharmacy is owned by a publicly traded corporation, is owned by a corporation that has at least $100 million in taxable assets in the state, or has been continuously licensed for the past 10 years. Finally, the amendment requires wholesale distributors to credential physicians, dentists, and pharmacies that purchase Schedule II or III drugs from the distributor. The amended bill still repeals the regulation of pain clinics, as in the original bill. The companion to H.B. 7095, H.B. 7097, which repeals the Office of Drug Control and the drug database, has not yet been referred to any committees.